EXOCRINE PANCREATIC DUCTOGRAMS IN INSULIN-DEPENDENT DIABETES-MELLITUS

被引:0
作者
NAKANISHI, K
KOBAYASHI, T
MIYASHITA, H
OKUBO, M
SUGIMOTO, T
MURASE, T
HASHIMOTO, M
FUKUCHI, S
KOSAKA, K
机构
[1] TORANOMON GEN HOSP, DEPT GASTROENTEROL, TOKYO, JAPAN
[2] OKINAKA MEM INST MED RES, TOKYO, JAPAN
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: To examine the prevalence of abnormal pancreatic ductograms in patients with insulin-dependent diabetes mellitus (IDDM) and to determine the clinical characteristics of those patients. Methods: Pancreatic exocrine morphology was studied by endoscopic retrograde pancreatography (ERP) in 43 patients with IDDM, 12 patients with islet cell antibody (ICA)-positive non-insulin-dependent diabetes mellitus (NIDDM), and 22 patients with ICA-negative NIDDM. Results: ERP revealed a significantly higher prevalence of abnormal pancreatic ducts (dilation and stenosis, tortuosity, obstruction, and intraductal calculi) in the patients with IDDM (17/43, 40%) than in the patients with ICA-negative NIDDM (2/22, 9%, p = 0.018). IDDM patients who slowly progressed to insulin dependency more than 13 months after the onset of diabetes had a higher frequency of abnormal pancreatic ducts (13/22, 59%) than those who needed insulin therapy within 12 months after the onset (4/21, 19%, p = 0.016). There was no difference in duration of diabetes between the two groups. ICA-positive NIDDM patients also had a higher frequency of abnormal pancreatic ducts (7/12, 58%) than ICA-negative NIDDM patients (2/22, 9%, p = 0.0074). Conclusions: These results indicate that a high proportion of IDDM patients who have prolonged histories of non-insulin dependency with ICA suffer pancreatic exocrine impairment. A similarity between IDDM with a slowly progressive clinical course and fibrocalculous pancreatic diabetes seen in tropical countries also was suggested.
引用
收藏
页码:762 / 766
页数:5
相关论文
共 31 条
[1]  
Diabetes mellitus, 1985, WHO TECHNICAL REPORT, V727
[2]  
DONIACH I, 1973, Clinical Endocrinology, V2, P233, DOI 10.1111/j.1365-2265.1973.tb00425.x
[3]   FASTING PLASMA C-PEPTIDE, GLUCAGON STIMULATED PLASMA C-PEPTIDE, AND URINARY C-PEPTIDE IN RELATION TO CLINICAL TYPE OF DIABETES [J].
GJESSING, HJ ;
MATZEN, LE ;
FABER, OK ;
FROLAND, A .
DIABETOLOGIA, 1989, 32 (05) :305-311
[4]   ISLET CELL ANTIBODIES IDENTIFY LATENT TYPE-I DIABETES IN PATIENTS AGED 35-75 YEARS AT DIAGNOSIS [J].
GROOP, LC ;
BOTTAZZO, GF ;
DONIACH, D .
DIABETES, 1986, 35 (02) :237-241
[5]  
HARRIS M, 1979, DIABETES, V28, P1039
[6]  
Jarrett R J, 1979, Diabetes Care, V2, P196, DOI 10.2337/diacare.2.2.196
[7]   DIAGNOSIS AND GRADING OF CHRONIC-PANCREATITIS BY MORPHOLOGICAL CRITERIA DERIVED BY ULTRASOUND AND PANCREATOGRAPHY [J].
JONES, SN ;
LEES, WR ;
FROST, RA .
CLINICAL RADIOLOGY, 1988, 39 (01) :43-48
[8]  
KANEKO T, 1974, ENDOCRINOL JAPON, V21, P141
[9]  
KASUGAI T, 1972, GASTROENTEROLOGY, V63, P227
[10]   PANCREATIC CYTOKERATIN - AN ANTIGEN OF PANCREATIC EXOCRINE CELL AUTOANTIBODIES IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
KOBAYASHI, T ;
NAKANISHI, K ;
KAJIO, H ;
MORINAGA, S ;
SUGIMOTO, T ;
MURASE, T ;
KOSAKA, K .
DIABETOLOGIA, 1990, 33 (06) :363-370